A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung

Experimental and Therapeutic Medicine

Volumn 9, Issue 1, 2015, Pages 197-202

  Liang, Rui ^a   Chen, Tian Xing ^a   Wang, Zhi Qiang ^b   Jin, Ke Wei ^b   Zhang, Lian Yu ^c   Yan, Qing Na ^c   Zhang, Hui Hua ^a   Wang, Wan Pu ^a  

^a FIRST PEOPLE S HOSPITAL OF YUNNAN PROVINCE   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Large cell carcinoma; Lung cancer; Pathology; Retrospective analysis

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; PROTEIN P63; THYROID TRANSCRIPTION FACTOR 1;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER STAGING; CANCER SURGERY; CLEAR CELL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CYTOPATHOLOGY; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG; LYMPH NODE METASTASIS; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SMOKING; SURVIVAL RATE; SYMPTOM ASSESSMENT; TUMOR INVASION;

EID: 84919443808     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2075     Document Type: Article

References (30)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA-Cancer J Clin 63: 11-30, 2013.
2. Travis WD, Brambilla E, Muller-Hermelink HK and Harris CC (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004.
3. Hanagiri T, Oka S, Takenaka S, et al: Results of surgical resection for patients with large cell carcinoma of the lung. Int J Surg 8: 391-394, 2010.
4. Battafarano RJ, Fernandez FG, Ritter J, et al: Large cell neuro-endocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg 130: 166-172, 2005.
5. Zhang J, Yu JP, Yu WW, et al: Relationship between VEGF expression and dendritic cells and regulatory T cell distribution in large cell lung cancer. Zhongguo Zhong Liu Lin Chuang 39: 1501-1504, 20l2 (In Chinese).
6. Zhu R, Liu JM and Wang L: Clinical analysis of 109 cases of large cell lung cancer. Linchuang Zhongliuxue Zazhi 17: 912-914, 2012.
7. Kobold S, Völk S, Clauditz T, et al: Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells. J Thorac Oncol 8: 1032-1042, 2013.
8. Khaghanzadeh N, Mojtahedi Z, Ramezani M, Erfani N and Ghaderi A: Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adeno-carcinoma cells. Daru 20: 69, 2012.
9. Yousefi Z, Sarvari J, Nakamura K, et al: Secretomic analysis of large cell lung cancer cell lines using two-dimensional gel electrophoresis coupled to mass spectrometry. Folia Histochem Cytobiol 50: 368-374, 2012.
10. Sabater-Marco V, García-García JA and Roig-Vila JV: Basaloid large cell lung carcinoma presenting as cutaneous metastasis at the colostomy site after abdominoperineal resection for rectal carcinoma. J Cutan Pathol 40: 758-764, 2013.
11. Sun JM, Ahn MJ, Ahn JS, et al: Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer? Lung Cancer 77: 365-370, 2012.
12. Lubin JH and Caporaso NE: Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev 15: 517-523, 2006.
13. Xia Y, Li B, Gao N, et al: Expression of tumor-associated calcium signal transducer 2 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis. Oncol Lett 8: 1670-1674, 2014.
14. Rekhtman N, Tafe LJ, Chaft JE, et al: Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Mod Pathol 26: 511-522, 2013.
15. Buendia AJ, Sánchez J, Martinez CM and Navarro JA: Immunohistochemical characterization of a pulmonary large-cell carcinoma in a dog. Vet Pathol 45: 484-488, 2008.
16. Stojsic J, Stevic R, Kontic M, et al: Large cell lung carcinoma with unusual imaging feature, immunophenotype and genetic finding. Pathol Oncol Res 17: 175-179, 2011.
17. Pardo J, Martinez-Peñuela AM, Sola JJ, et al: Large cell carcinoma of the lung: an endangered species? Appl Immunohistochem Mol Morphol 17: 383-392, 2009.
18. Barbareschi M, Cantaloni C, Del Vescovo V, et al: Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis. Am J Clin Pathol 136: 773-782, 2011.
19. Watanabe R, Ito I, Kenmotsu H, et al: Large cell neuroendocrine carcinoma of the lung: is it possible to diagnose from biopsy specimens? Jpn J Clin Oncol 43: 294-304, 2013.
20. Doddoli C, Barlesi F, Chetaille B, et al: Large cell neuro-endocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery. Ann Thorac Surg 77: 1168-1172, 2004.
21. Mimae T, Yamashita M, Maeda A, et al: Large cell neuro-endocrine carcinoma of the lung. Kyobu Geka 62: 442-445, 2009.
22. Gollard R, Jhatakia S, Elliott M and Kosty M: Large cell/neuro-endocrine carcinoma. Lung Cancer 69: 13-18, 2010.
23. Tanaka Y, Ogawa H, Uchino K, et al: Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroen-docrine markers and tumor response to chemotherapy. J Thorac Cardiovasc Surg 145: 839-846, 2013.
24. Morbini P and Inghilleri S: Large-cell lung carcinoma with basaloid architecture and neuroendocrine differentiation: a new type of combined large-cell neuroendocrine carcinoma. Int J Surg Pathol 19: 252-258, 2011.
25. Fournel L, Falcoz PE, Alifano M, et al: Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience. Eur J Cardiothorac Surg 43: 111-114, 2013.
26. Rossi G, Cavazza A, Marchioni A, et al: Role of chemo-therapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 23: 8774-8785, 2005.
27. Li H, Wang C, Yu J, et al: Dend r itic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy 11: 1076-1083, 2009.
28. Zhao Q, Zhang H, Li Y, et al: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro. J Exp Clin Cancer Res 29: 118, 2010.
29. Saji H, Tsuboi M, Matsubayashi J, et al: Clinical response of large cell neuroendocrine carcinoma of the lung to periop-erative adjuvant chemotherapy. Anticancer Drugs 21: 89-93, 2010.
30. Shimada Y, Niho S, Ishii G, et al: Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens. Lung Cancer 75: 368-373, 2012.